Ocular posterior segment involvement in patients with antiphospholipid syndrome and systemic lupus erythematosus

dc.contributor.authorKüçükkömürcü, Elvan
dc.contributor.authorÜnal, Ali Uğur
dc.contributor.authorEsen, Fehim
dc.contributor.authorÖzen, Gülsen
dc.contributor.authorDireşkeneli, Haner
dc.contributor.authorKazoko?lu, Haluk
dc.date.accessioned2019-05-13T08:58:07Z
dc.date.available2019-05-13T08:58:07Z
dc.date.issued2018
dc.departmentHitit Üniversitesi, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü
dc.description.abstractPurpose: To describe posterior segment findings of antiphospholipid syndrome (APS) and compare them with systemic lupus erythematosus (SLE). Methods: A total of 11 patients with primary APS, 29 secondary APS patients, and 29 SLE patients without APS were included. All patients were referred from rheumatology clinic for detailed ophthalmologic examination. When patients had suspicious lesions, fundus fluorescein angiography was performed (n = 56). Results: The most common retinal examination finding was peripheral venous tortuosity (17.5%) in APS, which was not observed in SLE group. Common FFA findings were pigment epithelial window defects (10%) and vascular filling delays (7.5%) in APS, which were observed in 27.5% and 3.5% of patients with SLE consecutively. Conclusion: Venous tortuosity was significantly more in patients with APS. There was no significant difference for other ocular findings between the groups. Ocular complication rate was lower compared to earlier reports, probably due to better management of disease activity with current treatment protocols. © 2018, © 2018 Taylor & Francis Group, LLC.
dc.identifier.citationKüçükkömürcü, E., Ünal, A. U., Esen, F., Özen, G., Direşkeneli, H., Kazokoglu, H. (2018). Ocular posterior segment involvement in patients with antiphospholipid syndrome and systemic lupus erythematosus. Ocular Immunology and Inflammation, 1-6.
dc.identifier.doi10.1080/09273948.2018.1552759
dc.identifier.issn0927-3948
dc.identifier.scopusqualityQ1
dc.identifier.urihttps://doi.org/10.1080/09273948.2018.1552759
dc.identifier.urihttps://hdl.handle.net/11491/1075
dc.identifier.wosWOS:000548907700001
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor and Francis Ltd
dc.relation.ispartofOcular Immunology and Inflammation
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectAntiphospholipid Syndromeen_US
dc.subjectDrusen-Like Depositen_US
dc.subjectFundus Fluorescein Angiographyen_US
dc.subjectSystemic Lupus Erythematosusen_US
dc.titleOcular posterior segment involvement in patients with antiphospholipid syndrome and systemic lupus erythematosus
dc.typeArticle

Dosyalar